Garry Nolan - Dec 2, 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Garry Nolan, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Dec 2, 2022
Transactions value $
-$14,575
Form type
4
Date filed
12/6/2022, 05:29 PM
Previous filing
Dec 2, 2022
Next filing
Mar 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Sale -$14.6K -1.1K -0.19% $13.25 592K Dec 2, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.